# US 2013/0296560 A1 · Novel Process For Preparation Of Bosentan

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0296560 A1
- Document ID: US20130296560A1
- Status: Published application
- Kind: A1
- Application number: 13/816,376
- Filed: 2011-03-28
- Published: 2013-11-07
- Earliest claimed: 2010-08-11
- Assignees: Megafine Pharma(P) Ltd.
- Inventors: Vijayavitthal Thippannachar Mathad; Navnath Chintaman Niphade; Kunal Madhav Jagtap; Chandrashekar Trimbak Gaikwad
- Web page: https://patentgrep.com/patent/US20130296560A1

## CPC

- C07D 239/69: Benzenesulfonamido-pyrimidines
- A61P 11/00: Drugs for disorders of the respiratory system
- C07D 239/52: Two oxygen atoms
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A novel ammonium salt of Bosentan of formula (VIII); has been disclosed. The salt may be either crystalline or amorphous or mixture of Crystalline and amorphous form. A novel single pot process for the preparations of ammonium salt of Bosentan has been disclosed. The process comprises reacting the 4,6-dichloro-5-(2-methoxyphenoxy)-2,2′-bipyrimidine with 4-tert-butylbenzenesulfonamide in the presence of solvent and a base; adding ethylene glycol to the reaction mass and isolating the ammonium salt of Bosentan. The ammonium salt of Bosentan is converted into Bosentan and further into Bosentan Monohydrate which are substantially free from dimer impurity and 6-hydroxy impurity.

## Claims

### Claim 1

An ammonium salt of Bosentan of formula (VIII); comprising an XRD pattern having characteristic peaks at 5.96, 6.79, 9.09, 9.26, 10.52, 16.64, 17.60, 18.14, 18.53, 22.49, 24.29, 24.91, and 27.5±0.2 degrees 2θ as shown in FIG. 1

### Claim 2

(canceled)

### Claim 3

An amorphous form of ammonium salt of Bosentan of formula (VIII), comprising an XRD pattern as shown in FIG. 2.

### Claim 4

A single pot process for the preparations of an ammonium salt of Bosentan of the formula (VIII), the process comprising:
reacting the 4,6-dichloro-5-(2-methoxyphenoxy)-2,2′-bipyrimidine of formula (III) with 4-tert-butylbenzenesulfonamide of formula (IV) in the presence of a solvent and a base; adding ethylene glycol of the formula (V) to the reaction mass, maintaining the reaction mass at the temperature of between 50° C. and 150° C., until completion; and isolating the ammonium salt of Bosentan of the formula (VIII)

### Claim 5 (depends on 4)

The process of claim 4, wherein the 4,6-dichloro-5-(2-methoxyphenoxy)-2,2′-bipyrimidine of formula (III) is reacted with 4-tert-butylbenzenesulfonamide of formula (IV) in the presence of a polar aprotic solvent selected from C3-C6 ketones comprising acetone, methyl isobutyl ketone or ethylmethyl ketone; nitriles comprising acetonitrile; C3-C6 amides comprising dimethyl formamide, dimethyl acetamide, N-methyl-2-pyrrolidone or hexamethyl phsopharamide; C2-C8 ethers and cyclic ether, substituted cyclic ethers, comprising diethyl ether, isopropyl ether, methyl tertiary butyl ether, tetrahydrofuran, 1,4-dioxan or 2-methyl tetrahydrofuran; dimethylsulfoxide or combinations thereof and a base is selected from organic or inorganic base, including but not limited to sodium carbonate, potassium carbonate, sodium bicarbonate, potassium bicarbonate, cesium carbonate, calcium carbonate, sodium hydroxide, potassium hydroxide, cesium hydroxide, barium hydroxide, lithium hydroxide or a mixture thereof.

### Claim 6

(canceled)

### Claim 7

(canceled)

### Claim 8

(canceled)

### Claim 9

(canceled)

### Claim 10

(canceled)

### Claim 11

(canceled)

### Claim 12 (depends on 4)

The process of claim 4, wherein the isolation of the ammonium salt of Bosentan of the formula (VIII) is carried out by
a. cooling the reaction mass followed by addition of water and adjusting the pH of the reaction mass to pH 1 to 4 using acid and extracting the aqueous reaction mass by suitable organic solvent followed by concentrating the organic layer to obtain residue; and
b. adding solvent and ammonia or ammonium hydroxide to the residue of step (a) and heating the obtained mixture till clear solution is obtained; followed by cooling the reaction mass, filtering and drying the ammonium salt of Bosentan of the formula (VIII).

### Claim 13 (depends on 12)

The process of claim 12, wherein the acid used in step (a) is selected from tartaric acid, oxalic acid, mandelic acid, fumaric acid, acetic acid, formic acid or from inorganic acids comprising hydrochloric acid, nitric acid, sulfuric acid, hydrobromic acid, para-toluene sulfonic acid and mixtures thereof and solvent used for extraction in step (a) is selected from aliphatic chlorinated hydrocarbons comprising dichloromethane, or dichloroethane; hydrocarbons comprising toluene, xylene, cyclohexanes, hexanes, or heptanes; C2-C6 alkyl acetates comprising ethyl acetate, isopropyl acetate, or butyl acetate; C2-C8 ethers comprising diethyl ether, isopropyl ether, or methyl tertiary butyl ether.

### Claim 14

(canceled)

### Claim 15

(canceled)

### Claim 16 (depends on 12)

The process of claim 12, the solvent used to dissolve the residue in step (b) is selected from a C3-C6 ketones comprising acetone, ethyl methyl ketone, or methyl isobutyl ketone; an aromatic hydrocarbons comprising toluene, or xylene; dimethylsulfoxide; dimethylformamide; a C1-C5 alkyl alcohol comprising methanol, ethanol, propanol, iso-propanol, n-butanol, tert-butanol or n-pentanol; acetonitrile; a C2-C6 alkyl acetates comprising ethyl acetate, isopropyl acetate, or butyl acetate; a C2-C8 ether comprising diethyl ether, isopropyl ether, or methyl tertiary butyl ether; tetrahydrofuran, water, and a base comprising ammonia, ammonium hydroxide, ammonium acetate, or ammonium carbonate, or combination thereof.

### Claim 17

(canceled)

### Claim 18

(canceled)

### Claim 19

(canceled)

### Claim 20 (depends on 12)

The process of claim 12, wherein the ammonium salt of Bosentan of formula (VIII) is purified using a solvent, wherein the solvent is the mixture of isopropyl acetate, ethanol and ammonia.

### Claim 21

(canceled)

### Claim 22

(canceled)

### Claim 23 (depends on 4)

The process of claim 4, wherein the ammonium salt of Bosentan of the formula (VIII) obtained is crystalline form having less than about 0.05% of dimer impurity of formula (VI) and less than about 0.40% 6-hydroxy impurity of formula (VII).

### Claim 24

(canceled)

### Claim 25

(canceled)

### Claim 26

(canceled)

### Claim 27

(canceled)

### Claim 28

A process for the preparation of an amorphous form of an ammonium salt of Bosentan, said process comprising providing a solution of crystalline or a mixture of crystalline and the amorphous form of the ammonium salt of Bosentan in a solvent, removing the solvent to form a solid residue and isolating the solid residue to obtain the amorphous form of the ammonium salt of Bosentan.

### Claim 29 (depends on 28)

The process of claim 28, wherein the amorphous form of the ammonium salt of Bosentan of the formula (VIII) has less than about 0.05% of dimer impurity of formula (VI) and less than about 0.3% 6-hydroxy impurity of formula (VII).

### Claim 30

(canceled)

### Claim 31

A process for the preparation of a Bosentan of the formula (I), the process comprising hydrolyzing the ammonium salt of the Bosentan of the formula (VIII) by adding water to the ammonium salt, followed by adjusting the pH of the reaction mass to a value in the range of 1 to 6 using acid, extracting the Bosentan of the formula (I) from the hydrolyzed reaction mass using a solvent selected from a halogenated hydrocarbon comprising dichloromethane, dichloroethane, or chloroform; a C2-C6 alkyl acetate comprising ethyl acetate, isopropyl acetate, or butyl acetate; a C2-C8 ether comprising diethyl ether, isopropyl ether, or methyl tertiary butyl ether; a hydrocarbon comprising toluene, xylene, a cyclohexane, a hexane, or a heptanes, washing organic layer with water, distilling off the solvent under reduced pressure to obtain Bosentan of the formula (I) as residue.

### Claim 32

(canceled)

### Claim 33

(canceled)

### Claim 34

(canceled)

### Claim 35

(canceled)

### Claim 36

(canceled)

### Claim 37

(canceled)

### Claim 38 (depends on 31)

The process of claim 31, further comprising purification of the Bosentan of the formula (I) by treating it with a solvent selected from a nitrile comprising acetonitrile; an alcohol comprising ethanol, methanol, or propanol; water or mixtures thereof and subsequently heating the mixture to reflux temperature followed by gradually cooling the mixture to 0° C. to 50° C.; maintaining the mixture at same temperature for 30 to 60 minutes and isolating pure Bosentan of formula (I).

### Claim 39

(canceled)

### Claim 40

(canceled)

### Claim 41 (depends on 31, 38)

The process of claim 31 or claim 38, wherein the Bosentan of the formula (I) has less than 0.02% of dimer impurity of formula (VI) and less than 0.03% of 6-hydroxy impurity of formula (VII).

### Claim 42

(canceled)

### Claim 43

A process for the preparation of a Bosentan monohydrate of the formula (II), the process comprising dissolving the Bosentan of the formula (I) in a solvent; heating the mixture to get a clear solution, adding activated charcoal as decolorizing agent to the clear solution, continuing the heating followed by removing the activated charcoal by filtration; adding water to the filtered solution, cooling the filtered solution to 20° C. to 30° C. to precipitate the pure Bosentan monohydrate of the formula (II), and isolating highly pure Bosentan monohydrate of the formula (II)

### Claim 44

The process as claimed in 43, wherein the solvent used in the preparation of the Bosentan monohydrate of the formula (II) is an alcohol comprising methanol, ethanol, propanol, or butanol.

### Claim 45

(canceled)

### Claim 46 (depends on 43)

The process of claim 43, wherein the Bosentan monohydrate of the formula (II) has less than 0.01% dimer impurity of formula (VI) and less than 0.02% of 6-hydroxy impurity of formula (VII).

### Claim 47

(canceled)
